BST1
BST1 (bone marrow stromal cell antigen 1, also known as CD157) is a cell-membrane, GPI-anchored enzyme of the ADP-ribosyl cyclase family. It synthesises and hydrolyses cyclic ADP-ribose, a second messenger that drives intracellular calcium release, and is linked to pre-B-cell growth. Browse Assay Genie's current range of BST1 research reagents below, or read on for the biology behind the target.
BST1 is a bifunctional enzyme. It catalyses the synthesis of cyclic ADP-beta-D-ribose (cADPR) from NAD(+) and also its hydrolysis to ADP-D-ribose (ADPR). Cyclic ADPR is an endogenous second messenger that elicits calcium release from intracellular stores, so BST1 activity feeds into the regulation of intracellular calcium mobilisation. UniProt also notes that the protein may be involved in pre-B-cell growth.
The BST1 gene encodes a glycosylphosphatidylinositol-anchored molecule that sits at the cell membrane. It was first described on stromal cell lines derived from bone marrow, where it facilitates pre-B-cell growth. The protein belongs to the ADP-ribosyl cyclase family, and its deduced amino acid sequence shows 33% similarity with CD38, another member of the CD molecule group. Researchers working on the BST1 protein often study it alongside CD38 for this reason. The mouse and rat orthologues are both designated Bst1.
The protein is known by several names: bone marrow stromal cell antigen 1, BST-1, CD157, cADPR2 and, in UniProt, ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2. Its disease relevance was first noted in rheumatoid arthritis, where BST1 expression is enhanced in bone marrow stromal cell lines derived from patients. The polyclonal B-cell abnormalities seen in this condition may be attributed, at least in part, to BST1 overexpression in the stromal cell population. This makes the BST1 gene and its product a useful subject for studies of stromal support of B-lymphocyte development and of NAD(+)-derived calcium signalling.
BST1 produces and degrades cyclic ADP-ribose, a second messenger that triggers calcium release from intracellular stores.
BST1 is a stromal GPI-anchored molecule that facilitates pre-B-cell growth, making it relevant to B-lymphocyte biology.
BST1 expression is enhanced in bone marrow stromal cell lines from rheumatoid arthritis patients, linking it to B-cell abnormalities.
As an ADP-ribosyl cyclase related to CD38, BST1 is studied in NAD(+)-consuming enzyme pathways.
BST1 catalyses both the synthesis of cyclic ADP-ribose from NAD(+) and its hydrolysis to ADP-ribose. Cyclic ADP-ribose is a second messenger that releases calcium from intracellular stores, so BST1 helps regulate calcium mobilisation. It may also be involved in pre-B-cell growth.
Yes. CD157 is an alias of BST1, which is also written BST-1 or cADPR2. The official name is bone marrow stromal cell antigen 1, and UniProt lists it as ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2. HGNC places it in the CD molecules gene group.
BST1 expression is enhanced in bone marrow stromal cell lines from rheumatoid arthritis patients, and its overexpression may contribute to polyclonal B-cell abnormalities. Its sequence is 33% similar to CD38. Orthologues exist in mouse and rat, both named Bst1; check the datasheet of any product for its validated reactivity.
Other bone marrow stromal cell antigen family members with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt Q10588; product specifications from Assay Genie datasheets.